HCI · HCI Group, Inc.

Restricted stock grant of 750 shares effective 6/11/2026: The restricted shares will vest on 5/27/2027. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement.

Restricted stock grant of 750 shares effective 6/11/2026: The restricted shares will vest on 5/27/2027. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement.

Restricted stock grant of 750 shares effective 6/11/2026: The restricted shares will vest on 5/27/2027. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement.

Restricted stock grant of 750 shares effective 6/11/2026: The restricted shares will vest on 5/27/2027. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement.

Restricted stock grant of 750 shares effective 6/11/2026: The restricted shares will vest on 5/27/2027. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement.

13,379 shares were surrendered to cover the estimated federal tax liability associated with the vesting of 34,000 restricted shares on May 22, 2026.

13,379 shares were surrendered to cover the estimated federal tax liability associated with the vesting of 34,000 restricted shares on May 22, 2026.

13,384 shares were surrendered to cover the estimated federal tax liability associated with the vesting of 34,000 restricted shares on May 22, 2026.

13,379 shares were surrendered to cover the estimated federal tax liability associated with the vesting of 34,000 restricted shares on May 22, 2026.

The options were granted pursuant to the HCI Group, Inc. 2012 Omnibus Incentive Plan.

The options were granted on January 7, 2017 at an exercise price of $40.00 per share, in excess of the $39.71 market value. All options have vested and may be exercised at any time up to and including January 7, 2027.

Restricted stock grant of 1,251 shares effective 12/19/2025: Restrictions will lapse and the restricted shares will vest as follows: 417 shares on each of October 23, 2026, October 23, 2027, and October 23, 2028. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement dated 12/19/2025.

Restricted stock grant of 1,251 shares effective 12/19/2025: Restrictions will lapse and the restricted shares will vest as follows: 417 shares on each of October 23, 2026, October 23, 2027, and October 23, 2028. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement dated 12/19/2025.

Restricted stock grant of 621 shares effective 12/19/2025: Restrictions will lapse and the restricted shares will vest as follows: 207 shares on each of October 23, 2026, October 23, 2027, and October 23, 2028. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement dated 12/19/2025.

Restricted stock grant of 1,251 shares effective 12/19/2025: Restrictions will lapse and the restricted shares will vest as follows: 417 shares on each of October 23, 2026, October 23, 2027, and October 23, 2028. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement dated 12/19/2025.

Restricted stock grant of 750 shares effective 7/21/2025: The restricted shares will vest on 5/22/2026. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement.

Restricted stock grant of 750 shares effective 7/21/2025: The restricted shares will vest on 5/22/2026. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement.

Restricted stock grant of 750 shares effective 7/21/2025: The restricted shares will vest on 5/22/2026. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement.

Restricted stock grant of 750 shares effective 7/21/2025: The restricted shares will vest on 5/22/2026. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement.

Restricted stock grant of 750 shares effective 7/21/2025: The restricted shares will vest on 5/22/2026. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement.

223 shares were surrendered to cover the minimum federal tax liability associated with the vesting of 750 restricted shares on February 26, 2025.

Restricted stock grant of 3,000 shares effective 2/26/2021: Restricted shares will lapse and the restricted shares will vest as follows: 750 shares on each of February 26, 2022, February 26, 2023, February 26, 2024, and February 26, 2025. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement dated 2/26/2021.

223 shares were surrendered to cover the minimum federal tax liability associated with the vesting of 750 restricted shares on February 26, 2025.

Restricted stock grant of 3,000 shares effective 2/26/2021: Restricted shares will lapse and the restricted shares will vest as follows: 750 shares on each of February 26, 2022, February 26, 2023, February 26, 2024, and February 26, 2025. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement dated 2/26/2021.

223 shares were surrendered to cover the minimum federal tax liability associated with the vesting of 750 restricted shares on February 26, 2025.

Restricted stock grant of 3,000 shares effective 2/26/2021: Restricted shares will lapse and the restricted shares will vest as follows: 750 shares on each of February 26, 2022, February 26, 2023, February 26, 2024, and February 26, 2025. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement dated 2/26/2021.

Restricted stock grant of 750 shares effective 6/12/2024: The restricted shares will vest on 5/22/2025. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement.

Restricted stock grant of 750 shares effective 6/12/2024: The restricted shares will vest on 5/22/2025. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement.

Restricted stock grant of 750 shares effective 6/12/2024: The restricted shares will vest on 5/22/2025. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement.

Restricted stock grant of 750 shares effective 6/12/2024: The restricted shares will vest on 5/22/2025. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement.

Restricted stock grant of 750 shares effective 6/12/2024: The restricted shares will vest on 5/22/2025. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement.

Restricted stock grant of 750 shares effective 6/12/2024: The restricted shares will vest on 5/22/2025. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement.

214 shares were surrendered to cover the minimum federal tax liability associated with the vesting of 875 restricted shares on May 20, 2024.

Restricted stock grant of 3,500 shares effective 5/26/2020: Restriction period will lapse and the restricted shares will vest as follows: 875 shares on each of May 20, 2021, May 20, 2022, May 20, 2023 and May 20, 2024. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement dated 5/26/2020.

214 shares were surrendered to cover the minimum federal tax liability associated with the vesting of 875 restricted shares on May 20, 2024.

Restricted stock grant of 3,500 shares effective 5/26/2020: Restriction period will lapse and the restricted shares will vest as follows: 875 shares on each of May 20, 2021, May 20, 2022, May 20, 2023 and May 20, 2024. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement dated 5/26/2020.

214 shares were surrendered to cover the minimum federal tax liability associated with the vesting of 875 restricted shares on May 20, 2024.

Restricted stock grant of 3,500 shares effective 5/26/2020: Restriction period will lapse and the restricted shares will vest as follows: 875 shares on each of May 20, 2021, May 20, 2022, May 20, 2023 and May 20, 2024. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement dated 5/26/2020.

214 shares were surrendered to cover the minimum federal tax liability associated with the vesting of 875 restricted shares on May 20, 2024.

Restricted stock grant of 3,500 shares effective 5/26/2020: Restriction period will lapse and the restricted shares will vest as follows: 875 shares on each of May 20, 2021, May 20, 2022, May 20, 2023 and May 20, 2024. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement dated 5/26/2020.

Restricted stock grant of 200,000 shares effective 4/17/2024: If at any time the Fair Market Value equals or exceeds $200 for 30 consecutive trading days (the "Vesting Trigger Date"), the restricted shares will vest and the restrictions will lapse as follows. 50,000 of the restricted shares on the later of the Vesting Trigger Date or March 15, 2025; March 15, 2026; March 15, 2027; and March 15, 2028. No portion of the restriction period will lapse six years and one day after the grant date. All remaining restricted shares will be forfeited at that time. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement dated 4/17/2024.

The reporting person is seeking to improve modestly the diversification of his investment holdings.

The reported price in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $115.70 to $117.42 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reporting person is seeking to improve modestly the diversification of his investment holdings.

The reporting person is seeking to improve modestly the diversification of his investment holdings.

The reporting person is seeking to improve modestly the diversification of his investment holdings.

The reported price in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $116.00 to $116.085 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reporting person is seeking to improve modestly the diversification of his investment holdings.

The reported price in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $117.0029 to $118.00 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reporting person is seeking to improve modestly the diversification of his investment holdings.

The reporting person is seeking to improve modestly the diversification of his investment holdings.

The reported price in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $113.77 to $116.26 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, jor the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reporting person holds voting and investment power of all shares held by Universal Finance & Investments, LLC.

The reporting person is seeking to improve modestly the diversification of his investment holdings.

The reported price in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $118.63 to $119.50 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, jor the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reporting person holds voting and investment power of all shares held by Universal Finance & Investments, LLC.

The reporting person is seeking to improve modestly the diversification of his investment holdings.

The reported price in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $116.00 to $118.025 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reporting person is seeking to improve modestly the diversification of his investment holdings.

The reported price in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $118.00 to $118.17 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reporting person is seeking to improve modestly the diversification of his investment holdings.

The reported price in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $115.98 to $116.69 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reporting person is seeking to improve modestly the diversification of her investment holdings.

The reporting person is seeking to improve modestly the diversification of his investment holdings.

The reported price in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $116.382 to $117.745 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reporting person is seeking to improve modestly the diversification of his investment holdings.